JPMorgan: Probability of Spot Ethereum ETF Approval in May Is Not Over 50%
Nikolaos Panigirtzoglou, Managing Director at JPMorgan, stated that the probability of the approval of a spot Ethereum ETF in May is not over 50%. He mentioned, "We think for the SEC to approve a spot Ethereum ETF in May, it needs to categorize Ethereum as a commodity (similar to Bitcoin) rather than a security. This is far from certain, and I think the probability of the SEC categorizing Ethereum as a commodity before May is not over 50%." According to Panigirtzoglou, the SEC may continue to treat all cryptocurrencies other than Bitcoin as securities.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Liquidity Unconcerned? The Federal Reserve Hits 'Pause' Again, Ceasing Reserve Management Bond Purchases Until Mid-October
The Federal Reserve announced on Monday that it will not conduct short-term Treasury bond purchases for reserve management purposes in the next phase for the second consecutive month, indicating that policymakers are satisfied with the level of bank reserves in the financial system.

Trump connects with Jensen Huang: Slams AI threat as a "scam" and strongly supports data centers, calling them the "oil of the future"
Trump participated in a live call with Jensen Huang, denouncing the AI threat narrative as a scam and stating that data centers are the oil of the future. Despite Nvidia's stock price dropping due to slowdown concerns, Jensen Huang still responded to security warnings.

AI Risks and Calls for "Slowdown" Intensify; U.S. Cybersecurity Stocks Surge Collectively
On Monday, cybersecurity stocks generally rose. As concerns grow among investors about the potential harm artificial intelligence could cause to humanity, and some industry leaders call for slowing down AI development, capital is shifting toward the cybersecurity and related enterprise software sectors.

Telix Pharma CFO Darren Charlton Smith acquires 2,071 common shares for AUD 19,999.58